PATENT CLAIM ANALYSIS

Application Number: 16125252
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "313000"]

Abstract:
Analgesic compositions comprise an aminoquinoline together with an opioid, a non-steroidal anti-inflammatory drug (NSAID), a NE/5-HT reuptake inhibitor, or a combination thereof. The aminoquinoline potentiates bioactivity of opioids, NSAIDs and NE/5-HT reuptake inhibitors.

Claim (Index 46):
A method for preventing the development of chronic pain in an individual after the individual has sustained an injury, chemically-induced nerve damage and/or pathologically-induced nerve damage which comprises administering to the individual an effective amount of the composition of  claim 1 .

Metadata:
- Claim Count in Document: 128.0
- Percentile: 97.0
- Lexical Diversity: 1.32258
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15318964', '12083110', '09171697', '13102705', '15279576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7586639444359191
- 35 USC 102 Novelty (BERT): 0.5845740301979587
- Combined Prediction Score: 0.7412549530121231
- Mean Citation Score: 349.545086
- Max Citation Score: 563.5349
- Similarity Product: 355.81334335740206

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test